These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 52762)

  • 1. Androgen metabolism in the hypertrophic prostate.
    Wilson JD; Gloyna RE; Siiteri PK
    J Steroid Biochem; 1975; 6(3-4):443-5. PubMed ID: 52762
    [No Abstract]   [Full Text] [Related]  

  • 2. Dihydrotestosterone in prostatic hypertrophy. II. The formation and content of dihydrotestosterone in the hypertrophic canine prostate and the effect of dihydrotestosterone on prostate growth in the dog.
    Gloyna RE; Siiteri PK; Wilson JD
    J Clin Invest; 1970 Sep; 49(9):1746-53. PubMed ID: 4194769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Is the prostatic adenoma of hormonal origin].
    Bercovici JP; Morfin R; Charles JF
    Nouv Presse Med; 1975 Feb; 4(7):475-8. PubMed ID: 48234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benign prostatic hyperplasia: a disorder of androgen metabolism in the male.
    Horton R
    J Am Geriatr Soc; 1984 May; 32(5):380-5. PubMed ID: 6201524
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolism and action of steroid hormones on human benign prostatic hyperplasia and prostatic carcinoma grown in organ culture.
    Lasnitzki I
    J Steroid Biochem; 1979 Jul; 11(1B):625-30. PubMed ID: 90755
    [No Abstract]   [Full Text] [Related]  

  • 6. Conversion of 3H-testosterone to dihydrotestosterone in human hypertrophic prostatic tissue.
    Baranowska B; Zgliczyński S
    Nuklearmedizin; 1979; 18(6):297-9. PubMed ID: 94161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgens and estrogens in the plasma and prostatic tissue of normal dogs and dogs with benign prostatic hypertrophy.
    Lloyd JW; Thomas JA; Mawhinney MG
    Invest Urol; 1975 Nov; 13(3):220-22. PubMed ID: 53217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretion of dihydrotestosterone by human prostate in benign prostatic hypertrophy.
    Mahoudeau JA; Delassalle A; Bricaire H
    Acta Endocrinol (Copenh); 1974 Oct; 77(2):401-7. PubMed ID: 4138446
    [No Abstract]   [Full Text] [Related]  

  • 9. Benign prostatic hyperplasia: etiological considerations.
    Walsh PC
    Prog Clin Biol Res; 1976; 6():1-8. PubMed ID: 66685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentration of dihydrotestosterone and 3 alpha-androstanediol in naturally occurring and androgen-induced prostatic hyperplasia in the dog.
    Moore RJ; Gazak JM; Quebbeman JF; Wilson JD
    J Clin Invest; 1979 Oct; 64(4):1003-10. PubMed ID: 90055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of a 5 alpha-reductase inhibitor on androgen-mediated growth of the dog prostate.
    Wenderoth UK; George FW; Wilson JD
    Endocrinology; 1983 Aug; 113(2):569-73. PubMed ID: 6872940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydrotestosterone in prostatic hypertrophy. I. The formation and content of dihydrotestosterone in the hypertrophic prostate of man.
    Siiteri PK; Wilson JD
    J Clin Invest; 1970 Sep; 49(9):1737-45. PubMed ID: 4194768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
    Habib FK; Ross M; Tate R; Chisholm GD
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):137-44. PubMed ID: 9135694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benign prostatic hyperplasia: a disorder of androgen metabolism in the male.
    Horton R
    Am J Nephrol; 1982; 2(3):157-63. PubMed ID: 6184994
    [No Abstract]   [Full Text] [Related]  

  • 15. Androgen and prostatic stroma.
    Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G
    Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro studies of testosterone and 5alpha-dihydrotestosterone binding in benign prostatic hypertrophy.
    Steins P; Krieg M; Hollmann HJ; Voigt KD
    Acta Endocrinol (Copenh); 1974 Apr; 75(4):773-84. PubMed ID: 4136809
    [No Abstract]   [Full Text] [Related]  

  • 17. Uptake, metabolism and binding of various androgens in human prostatic tissue: in vivo and in vitro studies.
    Becker H; Horst HJ; Krieg M; Steins P; Voigt KD
    J Steroid Biochem; 1975; 6(3-4):447-52. PubMed ID: 52763
    [No Abstract]   [Full Text] [Related]  

  • 18. Quantification of androgen binding, androgen tissue levels, and sex hormone-binding globulin in prostate, muscle and plasma of patients with benign prostatic hypertrophy.
    Krieg M; Bartsch W; Herzer S; Becker H; Voigt KD
    Acta Endocrinol (Copenh); 1977 Sep; 86(1):200-15. PubMed ID: 71838
    [No Abstract]   [Full Text] [Related]  

  • 19. Intraprostatic testosterone and dihydrotestosterone. Part II: concentrations after androgen hormonal manipulation in men with benign prostatic hyperplasia and prostate cancer.
    van der Sluis TM; Meuleman EJ; van Moorselaar RJ; Bui HN; Blankenstein MA; Heijboer AC; Vis AN
    BJU Int; 2012 Jan; 109(2):183-8. PubMed ID: 21992404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional differences in the testosterone to dihydrotestosterone ratio in the epididymis and vas deferens of adult mice.
    Jean-Faucher C; Berger M; Gallon C; de Turckheim M; Veyssiere G; Jean C
    J Reprod Fertil; 1986 Mar; 76(2):537-43. PubMed ID: 3701698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.